Zarrabian Saiid
Insider CIK 1495521 · DMPI President and CEO, Director · LJPC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KTRA Kintara Therapeutics, Inc. | P Buy | 2021-12-07 | 2021-12-08 | 38,109 | $0.64 | $24.4K | 55,500 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | P Buy | 2021-12-06 | 2021-12-08 | 11,891 | $0.59 | $7.0K | 17,391 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 2,715,004 | — | $0 | 2,715,004 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2020-06-26 | 2020-06-30 | 241,438 | — | $0 | 457,650 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2019-09-05 | 2019-09-09 | 216,212 | — | $0 | 216,212 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2019-09-05 | 2019-09-09 | 241,438 | — | $0 | 241,438 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | D To issuer deriv | 2019-04-30 | 2019-05-01 | 200,000 | — | $0 | 0 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2018-05-21 | 2018-05-22 | 836,465 | — | $0 | 836,465 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | P Buy | 2017-11-14 | 2017-11-16 | 5,900 | $0.84 | $5.0K | 5,900 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | P Buy | 2017-11-14 | 2017-11-16 | 55,000 | $0.82 | $45.1K | 55,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2017-11-03 | 2017-11-07 | 120,000 | — | $0 | 120,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2017-07-07 | 2017-07-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2017-07-07 | 2017-07-11 | 36,000 | — | $0 | 36,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | P Buy | 2015-05-14 | 2015-05-15 | 307 | $19.50 | $6.0K | 688 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2015-02-23 | 2015-02-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | P Buy | 2014-07-31 | 2014-08-05 | 381 | $9.53 | $3.6K | 381 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2014-04-03 | 2014-04-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2014-04-03 | 2014-04-07 | 13,000 | — | $0 | 13,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2013-11-21 | 2013-11-26 | 900,000 | — | $0 | 900,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2013-09-24 | 2013-10-11 | 18,907,498 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer | 2013-09-24 | 2013-10-11 | 10,360,892 | — | $0 | 1,480,442 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award | 2013-09-24 | 2013-10-11 | 3,981,146 | — | $0 | 5,461,588 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award | 2013-04-29 | 2013-05-01 | 300,000 | — | $0 | 1,480,442 | SEC↗ |
| LJPC.QB LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2012-04-10 | 2012-04-12 | 11,541,334 | — | $0 | 11,541,334 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2012-04-10 | 2012-04-18 | 18,907,498 | — | $0 | 18,907,498 | SEC↗ |
| LJPC.QB LA JOLLA PHARMACEUTICAL CO | A Award | 2012-04-10 | 2012-04-12 | 10,360,892 | — | $0 | 11,541,334 | SEC↗ |
| LJPC.QB LA JOLLA PHARMACEUTICAL CO | A Award | 2012-04-10 | 2012-04-12 | 1,180,442 | — | $0 | 1,180,442 | SEC↗ |